<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01503216</url>
  </required_header>
  <id_info>
    <org_study_id>BMBF 0315668A</org_study_id>
    <nct_id>NCT01503216</nct_id>
  </id_info>
  <brief_title>Safety and Bioefficacy of Vitamin D2 and Vitamin D3</brief_title>
  <official_title>Safety and Bioefficacy of Vitamin D2 and Vitamin D3: Randomized Trial With Human Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ulrike Lehmann</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Martin-Luther-Universit채t Halle-Wittenberg</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the bioavailability of vitamin D2 and D3 as measured
      by the increase of the specific hydroxy forms in serum (25(OH)D2 and 25(OH)D3, respectively,
      and by total 25(OH)D.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study design: Human volunteers will receive supplements containing either vitamin D2 or D3
      for a period of 8 weeks. At baseline, after 4 weeks and after 8 weeks, 25(OH)D2, 25(OH)D3 and
      total 25(OH)D will be measured in serum as the main outcome variables. Additional outcome
      variables are the Ca concentration in serum, PTH concentration in serum, ambulatory blood
      pressure and heart rate, and renin expression in peripheral mononuclear cells.

      Groups/Cohorts Assigned Interventions

        1. Placebo group

        2. Vitamin D2-group Daily treatment with vitamin d2-supplements (containing 2000 IU per
           capsule)

        3. Vitamin D3-group Daily treatment with vitamin d3-supplements (containing 2000 IU per
           capsule)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change of 25-hydroxvitamin D</measure>
    <time_frame>after 4 and 8 weeks of supplementation</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>cholecalciferol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Human volunteers receiving cholecalciferol (vitamin D3) for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ergocalciferol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ergocalciferol 2000 IU per day for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo for 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>cholecalciferol</intervention_name>
    <description>cholecalciferol, 2000 IU per day, 8 weeks</description>
    <arm_group_label>cholecalciferol</arm_group_label>
    <other_name>Cholecalciferol, vitamin D3</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>ergocalciferol</intervention_name>
    <description>vitamin d2, 2000 IU per day for 8 weeks</description>
    <arm_group_label>Ergocalciferol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years

          -  healthy

        Exclusion Criteria:

          -  supplementation of vitamin d and calcium

          -  hypercalcemia

          -  hypercalciuria

          -  chronical illness (diabetes, kidney diseases, cardiovascular diseases)

          -  serum-creatinine above 115 mmol/l

          -  pregnancy or breastfeeding women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jutta Dierkes, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Institut f체r Agrar- und Ern채hrungswissenschaften</affiliation>
  </overall_official>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2011</study_first_submitted>
  <study_first_submitted_qc>December 30, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 2, 2012</study_first_posted>
  <last_update_submitted>October 7, 2012</last_update_submitted>
  <last_update_submitted_qc>October 7, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 10, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Martin-Luther-Universit채t Halle-Wittenberg</investigator_affiliation>
    <investigator_full_name>Ulrike Lehmann</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>randomized controlled trial</keyword>
  <keyword>vitamin D</keyword>
  <keyword>bioavailability</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

